Abstract

AbstractHeterocycles are important structural components in pharmacophores that are currently being used to treat several diseases. Among the various heterocyclic scaffolds, nitrogen and sulfur containing spiroheterocycles are essential structural motifs that constitute diverse biodynamic agents. In the last two decades, a paradigm shift has occurred in the synthesis of spirothiazolidin‐4‐ones by replacing conventional and multi‐step synthesis with green protocols, that use novel organo and nanocatalysts. In this review, literature on spirothiazolidin‐4‐ones from years 2000–2021 has been summarized into groups of different synthetic strategies and their potential biological activities.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call